Drug manufacturer deploys suite of NMR tools at sites in France, Hungary, and Germany.
Toronto, CA (April 15, 2008)—Advanced Chemistry Development, Inc., (ACD/Labs), an industry leader in the development of software for NMR processing, prediction, and data management, recently sold a suite of NMR software to one of the world’s leading pharmaceutical companies, Sanofi-Aventis, for use by five of its Process Development teams in production facilities in France, Germany, and Hungary.
NMR analysis is used in drug manufacturing to help identify impurities and degradants during filing and scale-up production process, and can also be used in a quality assurance capacity to help monitor the composition of the finished product.
Sanofi-Aventis needed a solution that would allow the analytical groups at some of its European Process Development sites to efficiently support internal clients with accurate NMR analysis. ACD/1D and 2D NMR Managers allow for off-instrument processing of analytical data and the ability to store results in a database searchable by structure as well as other parameters. ACD/Labs’ NMR Predictors provide predictions of 1D (1H, 13C, 15N, 19F, and 31P) and 2D NMR spectra to help in the rapid interpretation and identification of potential impurities and degradants.
“With the help of ACD/Labs software tools we expect to be able to provide results to our internal clients, more quickly and accurately than in the past,” said Philippe Cleon, Head of Structural Analysis in Process Development (Neuville, France). “We were impressed with the ease of use of the software as well as the accuracy of the results we were able to obtain with these tools.”
“Before and during the implementation process, Sanofi-Aventis will receive full technical support from our staff,” said Yves Lorrain, Director of Sales, Chemcad. Chemcad is the distributor of ACD/Labs products for parts of Western Europe, including France, Belgium, Spain, The Netherlands, Sweden, Norway, Finland, and Denmark.
ACD/Labs has a range of NMR products to assist everyone—from the chemist to the expert spectroscopist.
For more information about ACD/Labs NMR software and solutions, visit our website. www.acdlabs.com/nmr
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1994, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 145 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products is available at www.acdlabs.com.